心脏性休克:目前的证据,指导方针,前景和结果
Shashank Shekhar1, Ankit Agrawal2, Hussein Almadhoun3
1University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH.
Journal of cardiothoracic and vascular anesthesia
|February 20, 2026
概括
心脏性休克 (CS) 是医院死亡的主要原因,每年影响40,000-50,000人. 尽管取得了进展,但30天死亡率仍然很高,这突显了医疗保健的关键差距.
科学领域:
- 心脏病学 心脏病学
- 临界护理医学 临界护理医学
背景情况:
- 心脏性休克 (CS) 是急性心肌梗塞和其他心脏病的严重并发症.
- 它与高的住院死亡率有关,在30天内死亡率从30%到60%.
- 尽管治疗方面取得了进展,但CS患者的治疗结果仍然不够理想.
研究的目的:
- 审查目前对心脏性休克的定义和分期系统.
- 总结具有里程碑意义的临床试验和不断发展的CS管理指南建议.
- 突出结果的趋势,并确定患者护理中的持续差距.
主要方法:
- 这是一篇综述文章,综合了现有文献.
- 它包括从临床试验和指导方针文件中总结数据.
- 重点是定义,分期,治疗策略和结果.
主要成果:
- 在临床试验设计和CS的数据报告中存在显著的异质性.
- 对于CS患者的管理策略显示出相当大的变化.
- 尽管有治疗方面的进步,短期死亡率仍然令人担忧地高.
结论:
- 心脏性休克仍然是一个关键的临床挑战,预后不佳.
- 定义,分期和管理协议的标准化是必要的.
- 进一步的研究和优化护理策略对于改善CS结果至关重要.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
970
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
970
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Cardiomyopathy V: Interprofessional Care
506
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506
Cardiomyopathy II: Dilated Cardiomyopathy
634
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Cardiomyopathy III: Hypertrophic Cardiomyopathy
550
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiopulmonary Resuscitation III: AED Use
828
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
828


